NasdaqGM - Delayed Quote • USD
Harvard Bioscience, Inc. (HBIO)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 4:20 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 3 | 3 | 3 | 2 |
Avg. Estimate | 0.02 | 0.06 | 0.21 | 0.29 |
Low Estimate | 0.02 | 0.05 | 0.2 | 0.28 |
High Estimate | 0.03 | 0.07 | 0.23 | 0.3 |
Year Ago EPS | 0.06 | 0.04 | 0.14 | 0.21 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 3 | 3 | 3 | 2 |
Avg. Estimate | 25.79M | 29.1M | 114.87M | 125.55M |
Low Estimate | 25.6M | 28M | 114M | 125.1M |
High Estimate | 26M | 29.91M | 116.6M | 126M |
Year Ago Sales | 29.98M | -- | 112.25M | 114.87M |
Sales Growth (year/est) | -14.00% | -- | 2.30% | 9.30% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | 0.05 | 0.06 | 0.04 | 0.05 |
EPS Actual | 0.06 | 0.04 | 0.01 | 0.04 |
Difference | 0.01 | -0.02 | -0.03 | -0.01 |
Surprise % | 20.00% | -33.30% | -75.00% | -20.00% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0.02 | 0.06 | 0.21 | 0.29 |
7 Days Ago | 0.02 | 0.06 | 0.21 | 0.29 |
30 Days Ago | 0.02 | 0.06 | 0.21 | 0.29 |
60 Days Ago | 0.04 | 0.07 | 0.25 | 0.35 |
90 Days Ago | 0.04 | 0.07 | 0.25 | 0.35 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | HBIO | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -66.70% | -- | -- | 6.50% |
Next Qtr. | 50.00% | -- | -- | 12.00% |
Current Year | 50.00% | -- | -- | 5.30% |
Next Year | 38.10% | -- | -- | 13.10% |
Next 5 Years (per annum) | 10.00% | -- | -- | 11.09% |
Past 5 Years (per annum) | -6.95% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Reiterates | Benchmark: Speculative Buy to Speculative Buy | 6/22/2023 |
Maintains | Benchmark: Buy | 4/26/2023 |
Maintains | Keybanc: Overweight | 4/26/2023 |
Reiterates | Benchmark: Buy | 3/10/2023 |
Maintains | Keybanc: Overweight | 11/9/2022 |
Maintains | Keybanc: Overweight | 8/5/2022 |
Related Tickers
ANGO AngioDynamics, Inc.
5.81
+0.52%
UTMD Utah Medical Products, Inc.
65.92
-0.56%
HRAL Hear AtLast Holdings, Inc.
0.0010
0.00%
ICUI ICU Medical, Inc.
94.84
+0.33%
POCI Precision Optics Corporation, Inc.
5.60
-1.06%
OSUR OraSure Technologies, Inc.
5.32
+1.14%
DXR Daxor Corporation
9.65
-0.62%
HAE Haemonetics Corporation
90.99
+3.80%
KRMD KORU Medical Systems, Inc.
2.1900
0.00%
NEPH Nephros, Inc.
2.1900
+2.34%